These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8100332)

  • 1. Primary hypothyroidism and 131I-MIBG therapy in neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Garibaldi L; Borrone C
    Lancet; 1993 Jul; 342(8862):57. PubMed ID: 8100332
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Gattorno M; De Bernardi B; Borrone C
    Cancer; 1995 Nov; 76(9):1662-4. PubMed ID: 8635072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
    Sisson JC; Hutchinson RJ; Carey JE; Shapiro B; Johnson JW; Mallette SA; Wieland DM
    Eur J Nucl Med; 1988; 14(7-8):337-40. PubMed ID: 3181182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
    Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
    Bolster AA; Hilditch TE
    Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thyroid dysfunction due to 131I-metaiodobenzylguanidine in patients with neuroblastoma].
    Garrido Magaña E; Silva Estrada JA; Nishimura Meguro E; Rivera Hernández AJ; Zurita Cruz JN
    Rev Chil Pediatr; 2020 Jun; 91(3):379-384. PubMed ID: 32730518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
    Mastrangelo R; Tornesello A; Riccardi R; Lasorella A; Mastrangelo S; Mancini A; Rufini V; Troncone L
    Eur J Cancer; 1995; 31A(4):606-11. PubMed ID: 7576979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
    Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
    Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
    [No Abstract]   [Full Text] [Related]  

  • 11. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
    Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of neuroblastoma with 131I-MIBG.
    Mastrangelo R
    Med Pediatr Oncol; 1987; 15(4):157-8. PubMed ID: 3657703
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
    J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
    Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
    Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
    Klingebiel T; Reuland P; Feine U; Niethammer D
    Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic tumour dose of 131I-MIBG by accelerated diuresis.
    Darte L; Tennvall J
    Eur J Nucl Med; 1988; 14(9-10):512-4. PubMed ID: 3215192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.